Tekla Capital Management LLC Precision Biosciences Inc Call Options Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DTIL
# of Institutions
7Shares Held
2.56MCall Options Held
0Put Options Held
0-
Oup Management Co., LLC1.12MShares$5.3 Million0.86% of portfolio
-
Chi Advisors LLC New York, NY607KShares$2.86 Million0.1% of portfolio
-
Jacob Asset Management Of New York LLC Hermosa Beach, CA390KShares$1.84 Million0.19% of portfolio
-
Vericrest Private Wealth Newtown, PA155KShares$730,1550.3% of portfolio
-
American Portfolios Advisors Holbrook, NY33.9KShares$160,1440.0% of portfolio
About PRECISION BIOSCIENCES INC
- Ticker DTIL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 110,818,000
- Market Cap $523M
- Description
- Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...